Brief: Medicinova To Support NIH-funded Expanded Access Clinical Trial To Evaluate Ibudilast

Medicinova

30/09/2024 14:05

Sept 30 (Reuters) - MediciNova Inc  MNOV.O :
    * MEDICINOVA TO SUPPORT NIH-FUNDED EXPANDED ACCESS CLINICAL
TRIAL
TO EVALUATE MN166 (IBUDILAST) IN AMYOTROPHIC LATERAL SCLEROSIS
(ALS)
    * MEDICINOVA INC - NIH AWARDS $22 MILLION FOR EAP TO
EVALUATE
MN-166 IN ALS

Source text for Eikon:  urn:newsml:reuters.com:*:nGNX2C4y6H
Further company coverage:  MNOV.O 

 ((Reuters.Briefs@thomsonreuters.com;))